Impaired Renal Function on Cholesterol Efflux Capacity, HDL Particle Number, and Cardiovascular Events
- PMID: 30072004
- PMCID: PMC6152844
- DOI: 10.1016/j.jacc.2018.05.043
Impaired Renal Function on Cholesterol Efflux Capacity, HDL Particle Number, and Cardiovascular Events
Figures
Similar articles
-
Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).Circulation. 2017 Jun 20;135(25):2494-2504. doi: 10.1161/CIRCULATIONAHA.116.025678. Epub 2017 Apr 27. Circulation. 2017. PMID: 28450350 Free PMC article. Clinical Trial.
-
Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease.Biomolecules. 2020 Sep 21;10(9):1348. doi: 10.3390/biom10091348. Biomolecules. 2020. PMID: 32967334 Free PMC article. Review.
-
Inflammation Alters Relationship Between High-Density Lipoprotein Cholesterol and Cardiovascular Risk in Patients With Chronic Kidney Disease: Results From KNOW-CKD.J Am Heart Assoc. 2021 Aug 17;10(16):e021731. doi: 10.1161/JAHA.120.021731. Epub 2021 Aug 7. J Am Heart Assoc. 2021. PMID: 34369187 Free PMC article.
-
HDL in CKD-The Devil Is in the Detail.J Am Soc Nephrol. 2018 May;29(5):1356-1371. doi: 10.1681/ASN.2017070798. Epub 2018 Feb 22. J Am Soc Nephrol. 2018. PMID: 29472417 Free PMC article. Review.
-
Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease.Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2120-7. doi: 10.1161/ATVBAHA.114.304172. Epub 2014 Jul 24. Arterioscler Thromb Vasc Biol. 2014. PMID: 25060791
Cited by
-
Reverse cholesterol transport: current assay methods, alterations with disease and response to therapeutic intervention.Front Cardiovasc Med. 2025 Jul 10;12:1608384. doi: 10.3389/fcvm.2025.1608384. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40709204 Free PMC article. Review.
-
Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?Biomedicines. 2021 May 16;9(5):554. doi: 10.3390/biomedicines9050554. Biomedicines. 2021. PMID: 34065648 Free PMC article. Review.
-
High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives.Cells. 2021 Mar 5;10(3):574. doi: 10.3390/cells10030574. Cells. 2021. PMID: 33807918 Free PMC article. Review.
-
High density lipoprotein particle size and function associate with new cardiovascular events in patients with chronic kidney disease.PLoS One. 2025 Apr 1;20(4):e0320803. doi: 10.1371/journal.pone.0320803. eCollection 2025. PLoS One. 2025. PMID: 40168425 Free PMC article.
-
Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis.Front Cardiovasc Med. 2021 Dec 13;8:774418. doi: 10.3389/fcvm.2021.774418. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34966797 Free PMC article.
References
-
- Bauer L, Kern S, Rogacev KS et al. HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease. J Am Coll Cardiol 2017;69:246–247. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical